Mrs Gupta will discuss the existing vaccine recommendations, coverage rates and promising future indications. What are the opportunities and threats from a vaccine maker’s perspective?
What are the challenges and opportunities for the universal immunization program rolled out in India? Discover what lies ahead for manufacturers of novel, high-price vaccines which currently have small chances of being integrated into routine vaccination schedules.
All this and much more will be discussed on April 11th 2012.
Get your questions ready!
Have a look at the Congress program here.
Ensure you join us at the event at the best possible ticket price by booking your place before the 27th January – register here.